Omega-3 Symposium – the latest news on long-chain Omega-3:
health benefits, sources, and future R&D needs
The AAOCS in collaboration with the Omega-3 Centre are hosting a one day omega 3 symposium on
November 7, with international and national experts covering all the major health attributes of long
chain omega-3, i.e. cardiovascular, metabolic, anti-inflammatory, cognitive and infant development.
We are also looking at sources, sustainability and bioavailability, which will include fish oil, krill oil,
algae oil and new land plant sources of omega-3 including long-chain omega-3 and ALA.
Program highlights (7th of November Newcastle NSW)





Prof Clemens von Schacky - University of Munich – update on the omega-3 index and
cardiovascular health
Adam Ismail – GOED – Omega 3 market overview
Assoc Prof Giovanni Turchini – Deakin University – Omega-3 and aquaculture
Dr Beverly Mühlhäusler – University of Adelaide - Development and omega 3
Dr Nils Hoem - Aker Biomarine Norway – Developments with krill oil
Registration for this symposium is $220
This symposium is part of the biennial AAOCS meeting: Fats & Oils – The food vs. Fuel Dilemma
Noah’s on the Beach, Newcastle, NSW
More information on the conference and deep frying workshop here
Dr Matt Miller
Secretary
Matt.miller@plantandfood.co.nz
Kevin Krail
CEO – Omega 3 Centre
kkrail@omega-3centre.com
Adam Ismail is Executive Director of the Global Organization for EPA and DHA
Omega-3s, where he has overseen growth since GOED’s founding in 2007 to over
150 members today, overturning a ban on fish oil imports in Europe, and
establishment of nutritional intake recommendations and health claims in multiple
countries. Previously, he worked for Cargill in charge of commercializing their
omega-3 food ingredient business, and at Health Strategy Consulting and Health
Business Partners on investment banking and strategy consulting projects.
Prof. Dr. Clemens von Schacky has been leading the unit of Preventive Cardiology
at the Ludwig Maximilians-University of Munich for more than 20 years. Using methods
from molecular biology to randomized clinical trials, he investigated topics such as omega3 fatty acids, aspirin, ACE-inhibitors, diabetes, and others resulting in 99 peer-reviewed
publications. Among other committees, he works for German Cardiac Society on the
German guidelines on Cardiovascular Prevention, and is member of the Board of Directors
of ISSFAL, the International Society For the Study of Fatty Acids and Lipids. Together with
WS Harris, he invented and defined the Omega-3 Index (later renamed “HS-Omega-3
Index®). He founded and owns a laboratory, Omegametrix, which measures the Omega-3
Index and other parameters for research projects and for clinical routine.
Assoc Prof Giovanni Turchini, and ARC fellow, is based at Deakin University,
Warrnambool. His research interests span from aquaculture, fish nutrition, fish oil
replacement and fatty acid metabolism in cultured aquatic species to lipid nutrition
and biochemistry, long-chain omega-3 fatty acids, seafood quality and traceability,
and ethical issues encountered in the fisheries and aquaculture sectors. His most
recent researches are about the roles of micronutrients (vitamins and minerals) as
co-factors for n-3 LC-PUFA biosynthesis in fish and mammals.
Dr Beverly Mühlhäusler is an NHMRC Career Development Award Fellow and head
of the Metabolic Health Unit of the FOODplus Research Centre at the University of
Adelaide. She has a long standing interest in perinatal nutrition and identifying
interventions for long-term metabolic health. At this meeting, Bev will discuss her work
focussing on the role of the omega-3 long chain polyunsaturated fatty acids in fetal and
infant nutrition, and whether maternal omega-3 supplementation might offer a way to
improve the metabolic health of future generations.
Dr Nils Hoem was educated M.Sc. Pharmacy at University of Oslo, Norway, in
1983 and finished a Dr. Philos. in Pharmacology at University of Oslo in 1991. He
was a Associate Professor at University of Oslo until 2000. After working as a
visiting scientist at University of Southern California from 2000-2001, he has held
Director positions at MDS Pharma Services Europe, Pronova Biopharma Norway
and finally joined Aker Biomarine Antarctic as a Chief Scientist in 2008